You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
The novel BH3 α-helix mimetic JY-1-106 induces apoptosis in a subset of cancer cells (lung cancer, colon cancer and mesothelioma) by disrupting Bcl-xL and Mcl-1 protein–protein interactions with Bak
|
---|---|
Published in |
Molecular Cancer, May 2013
|
DOI | 10.1186/1476-4598-12-42 |
Pubmed ID | |
Authors |
Xiaobo Cao, Jeremy L Yap, M Karen Newell-Rogers, Chander Peddaboina, Weihua Jiang, Harry T Papaconstantinou, Dan Jupitor, Arun Rai, Kwan-Young Jung, Richard P Tubin, Wenbo Yu, Kenno Vanommeslaeghe, Paul T Wilder, Alexander D MacKerell, Steven Fletcher, Roy W Smythe |
Abstract |
It has been shown in many solid tumors that the overexpression of the pro-survival Bcl-2 family members Bcl-2/Bcl-xL and Mcl-1 confers resistance to a variety of chemotherapeutic agents. We designed the BH3 α-helix mimetic JY-1-106 to engage the hydrophobic BH3-binding grooves on the surfaces of both Bcl-xL and Mcl-1. |
X Demographics
The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 14% |
Unknown | 6 | 86% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 6 | 86% |
Practitioners (doctors, other healthcare professionals) | 1 | 14% |
Mendeley readers
The data shown below were compiled from readership statistics for 67 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Japan | 1 | 1% |
United Kingdom | 1 | 1% |
Turkey | 1 | 1% |
Germany | 1 | 1% |
Unknown | 63 | 94% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 13 | 19% |
Student > Ph. D. Student | 11 | 16% |
Student > Bachelor | 7 | 10% |
Student > Doctoral Student | 6 | 9% |
Student > Master | 5 | 7% |
Other | 11 | 16% |
Unknown | 14 | 21% |
Readers by discipline | Count | As % |
---|---|---|
Chemistry | 14 | 21% |
Agricultural and Biological Sciences | 14 | 21% |
Biochemistry, Genetics and Molecular Biology | 7 | 10% |
Medicine and Dentistry | 6 | 9% |
Pharmacology, Toxicology and Pharmaceutical Science | 4 | 6% |
Other | 7 | 10% |
Unknown | 15 | 22% |
Attention Score in Context
This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 January 2017.
All research outputs
#4,495,793
of 22,710,079 outputs
Outputs from Molecular Cancer
#301
of 1,716 outputs
Outputs of similar age
#38,764
of 195,184 outputs
Outputs of similar age from Molecular Cancer
#2
of 11 outputs
Altmetric has tracked 22,710,079 research outputs across all sources so far. Compared to these this one has done well and is in the 80th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,716 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.7. This one has done well, scoring higher than 81% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 195,184 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 79% of its contemporaries.
We're also able to compare this research output to 11 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 81% of its contemporaries.